Q61.5
Medullary cystic kidney
Clinical Classification Guidelines
Inclusion Terms
- Nephronophthisis
- Sponge kidney NOS
Medical Intelligence & Overview
Medullary cystic kidney disease (MCKD), classified under ICD-10 code Q61.5, is a rare inherited condition that affects the kidneys' ability to function properly. This disorder is characterized by the development of cysts in the medullary region of the kidneys, ultimately leading to kidney damage and possible renal failure. Often mistaken for other cystic kidney disorders, medullary cystic kidney disease is distinct due to its specific genetic and pathological features. It is important for individuals diagnosed with this condition to understand its nature, potential causes, symptoms, and available management options.
Causes & Symptoms
Clinical Causes: Genetic mutations inherited in an autosomal recessive or dominant pattern Mutations affecting genes responsible for kidney structure and function Family history of similar kidney disorders Possible association with other systemic conditions
Key Symptoms: Progressive decline in kidney function Frequent urination, especially at night Increased thirst and fluid intake Blood in the urine High blood pressure Swelling in the legs, ankles, or face Poor growth in children Bone and mineral metabolism abnormalities as the disease progresses
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history, physical examinations, and various testing methods. Key diagnostic steps include: - Laboratory tests such as blood tests to evaluate kidney function and detect anemia or electrolyte imbalances. - Urinalysis to detect abnormalities like increased protein or blood. - Imaging studies, particularly ultrasound, revealing cystic changes localized to the medullary region of the kidneys. - Genetic testing to identify mutations associated with medullary cystic kidney disease. - Kidney biopsy in some cases, to examine tissue and confirm the pattern of cyst development and tissue changes characteristic of the disease.
Treatment Protocols: While there is currently no cure for medullary cystic kidney disease, management strategies focus on slowing disease progression and addressing symptoms. These include: - Regular monitoring of kidney function through blood tests and imaging. - Blood pressure control using medications like ACE inhibitors or angiotensin receptor blockers. - Dietary modifications to reduce salt intake and maintain electrolyte balance. - Management of anemia with appropriate therapies. - Treatment of bone mineral disorders if they develop. - Preparation for potential kidney replacement therapy, such as dialysis or transplantation, in advanced stages. - Genetic counseling for affected families to understand inheritance patterns and risks.
Clinical Advice & FAQs
Billing Guidance
Is Q61.5 a billable ICD-10 code?
Yes, Q61.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q61.5?
Clinical documentation must specify the nature of Medullary cystic kidney and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
